René Russo
2023 - Xilio Therapeutics
In 2023, René Russo earned a total compensation of $3M as President and Chief Executive Officer at Xilio Therapeutics, a 36% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $263,120 |
|---|---|
| Option Awards | $2,124,780 |
| Salary | $598,000 |
| Other | $14,010 |
| Total | $2,999,910 |
Russo received $2.1M in option awards, accounting for 71% of the total pay in 2023.
Russo also received $263.1K in non-equity incentive plan, $598K in salary and $14K in other compensation.
Rankings
In 2023, René Russo's compensation ranked 298th out of 2,647 executives tracked by ExecPay. In other words, Russo earned more than 88.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 298 out of 2,647 | 89th |
Division Manufacturing | 164 out of 1,447 | 89th |
Major group Chemicals And Allied Products | 112 out of 817 | 86th |
Industry group Drugs | 109 out of 783 | 86th |
Industry Pharmaceutical Preparations | 68 out of 555 | 88th |
Source: SEC filing on April 25, 2024.
Russo's colleagues
We found three more compensation records of executives who worked with René Russo at Xilio Therapeutics in 2023.